News & Updates

Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024

In patients with type 2 diabetes (T2D), moderate-intensity statin in combination with ezetimibe results in greater reductions in low-density lipoprotein cholesterol (LDL-C) and better prevention of adverse outcomes when compared with high-intensity statin monotherapy, suggests a study.

Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024
Use of mHealth more frequent in adults with high CVD risk
Use of mHealth more frequent in adults with high CVD risk
22 Jun 2024
Vaccine combo a promising therapy for hypertension
Vaccine combo a promising therapy for hypertension
18 Jun 2024